Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

NCT01072357 is registered in ClinicalTrials.gov with Reza Dana, MD as lead sponsor.

NCT NCT01072357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01072357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Lead sponsor
Reza Dana, MD
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2009
Completion date
January 31, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal graft failure, corneal neovascularization